日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evolution of Amoxicillin-Based Mono-Antibiotic Regimens for Helicobacter pylori Eradication: From Ineffectiveness to Innovation-A Systematic Review

基于阿莫西林的单药抗生素治疗幽门螺杆菌根除方案的演变:从无效到创新——系统评价

Shih, Chih-An; Wu, I-Ting; Wu, Deng-Chyang; Lei, Wei-Yi; Tsay, Feng-Woei; Tsai, Tzung-Jiun; Tsai, Chung-Hung; Wu, Ya-Chi; Tai, Wei-Chen; Hsu, Ping-I

Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024

2019年至2024年台湾幽门螺杆菌抗生素耐药性的序列变化

Wu, Pei-Jui; Tsay, Feng-Woei; Wu, Deng-Chyang; Yang, Jyh-Chin; Chuah, Seng-Kee; Chen, Kuan-Yang; Chen, Chien-Lin; Lee, Chia-Long; Shih, Chih-An; Liu, Yu-Hwa; Shiu, Sz-Iuan; Tai, Wei-Chen; Kuo, Chao-Hung; Lei, Wei-Yi; Kao, Sung-Shuo; Tsai, Tzung-Jiun; Feng, I-Che; Koseki, Mitsuhiro; Hsu, Ping-I; Sheu, Ming-Jen

Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Helicobacter pylori Infection: A Systematic Review

含抗生素联合质子泵抑制剂或伏诺拉赞的双重疗法治疗幽门螺杆菌感染:系统评价

Shih, Chih-An; Wu, Deng-Chyang; Shie, Chang-Bih; Hsu, Ping-I

Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection

预测幽门螺杆菌感染一线治疗混合疗法根除失败的独立危险因素

Chen, Chien-Lin; Wu, I-Ting; Wu, Deng-Chyang; Lei, Wei-Yi; Tsay, Feng-Woei; Chuah, Seng-Kee; Chen, Kuan-Yang; Yang, Jyh-Chin; Liu, Yu-Hwa; Kuo, Chao-Hung; Shiu, Sz-Iuan; Shie, Chang-Bih; Lin, Kuan-Hua; Lee, Chia-Long; Hsu, Ping-I

Application of artificial intelligence in endoscopic image analysis for the diagnosis of a gastric cancer pathogen-Helicobacter pylori infection

人工智能在内镜图像分析中应用于胃癌病原体——幽门螺杆菌感染的诊断

Lin, Chih-Hsueh; Hsu, Ping-I; Tseng, Chin-Dar; Chao, Pei-Ju; Wu, I-Ting; Ghose, Supratip; Shih, Chih-An; Lee, Shen-Hao; Ren, Jia-Hong; Shie, Chang-Bih; Lee, Tsair-Fwu

Update on the second-line treatment of Helicobacter pylori infection: a narrative review

幽门螺杆菌感染二线治疗进展:叙述性综述

Shih, Chih-An; Shie, Chang-Bih; Tai, Wei-Chen; Chuah, Seng-Kee; Lee, Hsi-Chang; Hsu, Ping-I

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users

比较直接抗病毒药物治疗丙型肝炎病毒感染在注射吸毒者和非吸毒者中的疗效

Hsu, Jui-Ting; Hsu, Ping-I; Shie, Chang-Bih; Chuah, Seng-Kee; Wu, I-Ting; Huang, Wen-Wei; Tang, Sheng-Yeh; Tsai, Kun-Feng; Kuo, Li-Fu; Ghose, Supratip; Hsu, Jui-Che; Shih, Chih-An

Prevalence and risk factors for Candida esophagitis among human immunodeficiency virus-negative individuals

人类免疫缺陷病毒阴性人群中念珠菌性食管炎的患病率和危险因素

Chen, Yan-Hua; Jao, Tzu-Ming; Shiue, Yow-Ling; Feng, I-Jung; Hsu, Ping-I

Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances

克拉霉素耐药性高低地区幽门螺杆菌感染一线治疗方案的最新进展

Shih, Chih-An; Shie, Chang-Bih; Hsu, Ping-I

Screening and prevention of hepatitis C virus reactivation during chemotherapy

化疗期间丙型肝炎病毒再激活的筛查和预防

Li, Yuan-Rung; Hu, Tsung-Hui; Chen, Wen-Chi; Hsu, Ping-I; Chen, Hui-Chun